CI Investments Inc’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$200K Sell
3,634
-32
-0.9% -$1.76K ﹤0.01% 704
2025
Q1
$259K Sell
3,666
-1,910
-34% -$135K ﹤0.01% 658
2024
Q4
$367K Buy
5,576
+832
+18% +$54.8K ﹤0.01% 570
2024
Q3
$333K Sell
4,744
-217
-4% -$15.2K ﹤0.01% 552
2024
Q2
$408K Sell
4,961
-431
-8% -$35.4K ﹤0.01% 503
2024
Q1
$471K Buy
5,392
+2,298
+74% +$201K ﹤0.01% 489
2023
Q4
$298K Sell
3,094
-515
-14% -$49.6K ﹤0.01% 532
2023
Q3
$319K Sell
3,609
-489
-12% -$43.2K ﹤0.01% 519
2023
Q2
$355K Sell
4,098
-323
-7% -$28K ﹤0.01% 531
2023
Q1
$430K Buy
4,421
+1,334
+43% +$130K ﹤0.01% 459
2022
Q4
$319K Sell
3,087
-129
-4% -$13.3K ﹤0.01% 519
2022
Q3
$273K Buy
3,216
+221
+7% +$18.8K ﹤0.01% 519
2022
Q2
$248K Sell
2,995
-783
-21% -$64.8K ﹤0.01% 570
2022
Q1
$291K Sell
3,778
-378
-9% -$29.1K ﹤0.01% 634
2021
Q4
$367K Buy
4,156
+167
+4% +$14.7K ﹤0.01% 652
2021
Q3
$308K Buy
3,989
+1,076
+37% +$83.1K ﹤0.01% 670
2021
Q2
$243K Sell
2,913
-1,203
-29% -$100K ﹤0.01% 711
2021
Q1
$311K Buy
4,116
+1,193
+41% +$90.1K ﹤0.01% 612
2020
Q4
$256K Buy
2,923
+1,064
+57% +$93.2K ﹤0.01% 629
2020
Q3
$141K Buy
1,859
+468
+34% +$35.5K ﹤0.01% 614
2020
Q2
$172K Buy
1,391
+230
+20% +$28.4K ﹤0.01% 535
2020
Q1
$98K Buy
1,161
+381
+49% +$32.2K ﹤0.01% 523
2019
Q4
$66K Buy
780
+698
+851% +$59.1K ﹤0.01% 588
2019
Q3
$6K Buy
+82
New +$6K ﹤0.01% 580
2016
Q3
Sell
-28,500
Closed -$2.22M 213
2016
Q2
$2.22M Hold
28,500
0.03% 150
2016
Q1
$2.35M Buy
+28,500
New +$2.35M 0.03% 141
2015
Q4
Sell
-141,000
Closed -$14.9M 182
2015
Q3
$14.9M Sell
141,000
-19,000
-12% -$2M 0.19% 96
2015
Q2
$21.9M Buy
160,000
+13,100
+9% +$1.79M 0.24% 96
2015
Q1
$18.3M Buy
+146,900
New +$18.3M 0.19% 91